EssentialFDA-lirLab Compliance AdvisorLaboratory Industry ReportNational Lab ReporterGail Dutton

FDA Proposal for LDTs Risks Serious Consequences

By | Oct 18, 2023

Lab leaders say that the increased level of scrutiny proposed for such tests would be a detriment to innovation and patient care.